Nootropic

Semax.

A Russian nootropic peptide — genuinely approved there, but with an evidence base that's mostly in Russian and in animals.

NootropicApproved (Russia)Sourced profile
Read this first

This is educational information, not medical advice, and The Peptide University does not sell peptides, supplies, or supplements. Many compounds discussed here are sold as “research chemicals” and are not approved for human use outside of clinical trials. Laws vary by country, and nothing here is a recommendation to obtain or use anything. Talk to a qualified clinician about your own situation.

✓ Approved for a specific use

Semax is a peptide developed in Russia and approved there for conditions like stroke recovery and cognitive impairment. It is not FDA-approved in the US.

How it works

It's related to a fragment of ACTH and is thought to raise neurotrophins like BDNF, supporting focus and memory. Nasal administration reaches the CNS within minutes, with BDNF effects reported to last up to 24 hours.

The evidence

The strongest human data is in neurological settings, especially ischemic stroke, from Russian clinical studies. A key limitation: much of the literature is Russian-language and animal-based, with relatively little in English-language peer review.

Safety

Reported as relatively well tolerated in its approved uses, but long-term and independent safety data outside Russia is limited. As with any compound, what's sold online as “semax” is a separate quality question.

FAQ

QIs it FDA-approved?

No — it's approved in Russia, not the US.

QWhy is the evidence hard to assess?

Much of it is Russian-language and animal-based, with limited English peer-reviewed trials.

Sources

This profile summarizes the following. Follow the links to read the originals — and remember that summaries age, so check for newer information.

Inclusion here is not endorsement of any source's claims; several are cited so you can compare how different outlets characterize the same evidence.

Questions & comments

No account, no login — leave a name or stay anonymous. Ask a question, add something the article missed, or answer someone else. Be kind and cite sources where you can.